Juno Minerals Limited logo

Juno Minerals Limited (JNOMF)

Market Closed
7 Aug, 20:00
OTC PINK OTC PINK
$
0. 02
0
0%
$
4.18M Market Cap
20.1 P/E Ratio
- Div Yield
10,000 Volume
0 Eps
$ 0.02
Previous Close
Add Transaction
Day Range
0.02 0.11
Year Range
0.01 0.11
Want to track JNOMF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

JNOMF closed Friday higher at $0.02, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, JNOMF stock lost -80%.
JNOMF is not paying dividends to its shareholders.
The last earnings report, released on Apr 07, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Juno Minerals Limited has completed 1 stock splits, with the recent split occurring on Oct 12, 2023.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on ASX (AUD).

JNOMF Chart

Juno Minerals Limited (JNOMF) FAQ

What is the stock price today?

The current price is $0.02.

On which exchange is it traded?

Juno Minerals Limited is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is JNOMF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.18M.

Has Juno Minerals Limited ever had a stock split?

Juno Minerals Limited had 1 splits and the recent split was on Oct 12, 2023.

Juno Minerals Limited Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Mordechai Elgrabli CEO
OTC PINK Exchange
AU0000134173 ISIN
Il Country
427 Employees
- Last Dividend
28 Sep 2023 Last Split
- IPO Date

Overview

Rekah Pharmaceutical Industry Ltd. is an established entity in the pharmaceutical sector based in Holon, Israel, with operations focused on the manufacture, marketing, sale, and distribution of a broad array of healthcare products. Since its inception in 1941, the company has grown to become a key player in the Israeli pharmaceutical industry, offering a wide range of prescription and over-the-counter (OTC) medications, dermo-cosmetic products, vitamins, and nutritional supplements. Its commitment to healthcare is reflected in its substantial portfolio of approximately 280 drugs catering to various medical needs.

Products and Services

Rekah Pharmaceutical Industry Ltd. offers a diverse range of products across multiple healthcare categories, ensuring comprehensive coverage of numerous medical conditions and health maintenance needs. These include:

  • Steroid Tablets: These are tailored for conditions requiring anti-inflammatory or immunosuppressant medications, showing the company’s involvement in providing critical care options for chronic and acute conditions.
  • Antibiotics: Including key categories like penicillin and cephalosporin, highlighting Rekah's role in combating bacterial infections through a range of effective antibiotic treatments.
  • Drops and Ointments for Eye Conditions: Designed to treat allergies, infections, and symptoms of dryness, this product line addresses a wide spectrum of eye health concerns, from minor irritations to more severe conditions.
  • Baby Products: Focused on the health and wellness of infants, these products underline the company’s commitment to providing safe and effective solutions for the youngest members of families, encompassing nutritional supplements to dermatological preparations.
  • Dermatological Preparations: This range demonstrates Rekah's investment in skin health, offering treatments for various dermatological issues and supporting overall skin condition and health with scientifically formulated products.

Contact Information

Address: 30 Hamelach Street, Holon, Israel, 5881904
Phone: 972 3 558 1233